Genus Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,088
Closed -$212K 225
2025
Q4
$212K Sell
1,088
-30,108
-97% -$7.17M 0.02% 188
2025
Q3
$8.77M Sell
31,196
-8,130
-21% -$2.07M 1.02% 28
2025
Q2
$8.6M Buy
39,326
+15,795
+67% +$2.55M 1.09% 24
2025
Q1
$3.29M Buy
+23,531
New +$3.83M 0.48% 71
2023
Q4
Sell
-105,041
Closed -$11.1M 324
2023
Q3
$11.1M Buy
105,041
+48,607
+86% +$5.63M 1.75% 13
2023
Q2
$6.72M Buy
+56,434
New +$5.83M 0.99% 27

Other funds holding ORCL

Genus Capital Management's ORCL Position: Q1 2026 in Review

Genus Capital Management sold out of Oracle (ORCL) in Q1 2026, closing a stake of 1,088 shares — an estimated $212K sold.

Genus Capital Management first reported a position in ORCL in Q2 2023 and held it in 6 quarters. The position peaked at $11.1M in Q3 2023. 3,499 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Genus Capital Management reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Genus Capital Management sold 1,088 Oracle shares in Q1 2026, an estimated $212K.
  • Genus Capital Management first reported a position in Oracle in Q2 2023 and held it in 6 quarters.
  • Genus Capital Management's Oracle position peaked at $11.1M in Q3 2023.
  • 3,499 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.